|
|
Previous Article | Table of Contents | Next Article 
Blood, 1 February 2001, Vol. 97, No. 3, pp. 799-804
TRANSPLANTATION
In vitro migratory capacity of CD34+ cells is related
to hematopoietic recovery after autologous stem cell
transplantation
Carlijn Voermans,
Marisha
L. K. Kooi,
Sjoerd Rodenhuis,
Hans van der
Lelie,
C. Ellen van der
Schoot, and
Winald R. Gerritsen
From the Divisions of Medical Oncology and Biometrics,
Netherlands Cancer Institute; CLB, Sanquin Blood Supply Foundation,
Laboratory for Experimental and Clinical Immunology, and Department of
Hematology, Academic Medical Center, University of Amsterdam; and
Department of Medical Oncology, Division of Gene Therapy Program,
University Hospital of Vrije Universiteit, Amsterdam, Netherlands.
To investigate whether the migratory ability of peripheral
blood-derived CD34+ cells of patients undergoing autologous
peripheral blood stem cell transplantation is related to the homing
efficiency of these cells, the migration in vitro of these cells was
determined and correlated with in vivo hematopoietic recovery. Large
inter-individual differences of the in vitro migratory ability of the
CD34+ cells were observed, ranging from 1.1% to 16.4% for
spontaneous migration and 6.2% to 40.8% for SDF-1-induced (100 ng/mL) migration. Significantly faster hematologic recovery was
observed in those patients who received transplanted CD34+
cells that showed high spontaneous and SDF-1-induced migration in
vitro (P < .05). Moreover, CD34+ cells from
healthy G-CSF-mobilized donors exhibited significantly higher
spontaneous and SDF-1-induced (P < .01) migration than CD34+ cells from patients mobilized with chemotherapy and
G-CSF. The lower migratory capacity in vitro of patient-derived
CD34+ cells was not due to lower expression of CXCR-4 but
probably reflected decreased motogenic behavior of the cells.
These results indicate that the migratory capacity of the cells is
important for hematopoietic recovery. The data suggest that the
engraftment potential of autologous stem cells is more or less impaired
by treatment before or during the mobilization procedure and might possibly be restored by in vitro manipulation of the cells. In addition, an exponential relation between CXCR-4 expression and number
of CD34+ cells that mobilized to the peripheral blood was
found (P < .001), suggesting that CXCR-4 expression
plays a role in the mobilization of CD34+ cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Lin, E. De Stanchina, X. K. Zhou, Y. She, D. Hoang, S. W. Cheung, B. Cassileth, and S. Cunningham-Rundles
Maitake Beta-Glucan Enhances Umbilical Cord Blood Stem Cell Transplantation in the NOD/SCID Mouse
Experimental Biology and Medicine,
March 1, 2009;
234(3):
342 - 353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bogani, V. Ponziani, P. Guglielmelli, C. Desterke, V. Rosti, A. Bosi, M.-C. Le Bousse-Kerdiles, G. Barosi, A. M. Vannucchi, and for the Myeloproliferative Disorders Research Cons
Hypermethylation of CXCR4 Promoter in CD34+ Cells from Patients with Primary Myelofibrosis
Stem Cells,
August 1, 2008;
26(8):
1920 - 1930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Voo, J. Eggermann, M. Dunaeva, C. Ramakers-van Oosterhoud, and J. Waltenberger
Enhanced functional response of CD133+ circulating progenitor cells in patients early after acute myocardial infarction
Eur. Heart J.,
January 2, 2008;
29(2):
241 - 250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fukuda, H. Bian, A. G. King, and L. M. Pelus
The chemokine GRO{beta} mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment
Blood,
August 1, 2007;
110(3):
860 - 869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Walter, U. Rochwalsky, J. Reinhold, F. Seeger, A. Aicher, C. Urbich, I. Spyridopoulos, J. Chun, V. Brinkmann, P. Keul, et al.
Sphingosine-1-Phosphate Stimulates the Functional Capacity of Progenitor Cells by Activation of the CXCR4-Dependent Signaling Pathway via the S1P3 Receptor
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2007;
27(2):
275 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Lorenowicz, J. van Gils, M. de Boer, P. L. Hordijk, and M. Fernandez-Borja
Epac1-Rap1 signaling regulates monocyte adhesion and chemotaxis
J. Leukoc. Biol.,
December 1, 2006;
80(6):
1542 - 1552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Goichberg, A. Kalinkovich, N. Borodovsky, M. Tesio, I. Petit, A. Nagler, I. Hardan, and T. Lapidot
cAMP-induced PKC{zeta} activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors
Blood,
February 1, 2006;
107(3):
870 - 879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Li, C. K. Y. Chuen, S. M. Lee, P. Law, T. F. Fok, P. C. Ng, C. K. Li, D. Wong, A. Merzouk, H. Salari, et al.
Small Peptide Analogue of SDF-1{alpha} Supports Survival of Cord Blood CD34+ Cells in Synergy with Other Cytokines and Enhances Their Ex Vivo Expansion and Engraftment into Nonobese Diabetic/Severe Combined Immunodeficient Mice
Stem Cells,
January 1, 2006;
24(1):
55 - 64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Walter, J. Haendeler, J. Reinhold, U. Rochwalsky, F. Seeger, J. Honold, J. Hoffmann, C. Urbich, R. Lehmann, F. Arenzana-Seisdesdos, et al.
Impaired CXCR4 Signaling Contributes to the Reduced Neovascularization Capacity of Endothelial Progenitor Cells From Patients With Coronary Artery Disease
Circ. Res.,
November 25, 2005;
97(11):
1142 - 1151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Lapidot, A. Dar, and O. Kollet
How do stem cells find their way home?
Blood,
September 15, 2005;
106(6):
1901 - 1910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Samira, C. Ferrand, A. Peled, A. Nagler, Y. Tovbin, H. Ben-Hur, N. Taylor, A. Globerson, and T. Lapidot
Tumor Necrosis Factor Promotes Human T-Cell Development in Nonobese Diabetic/Severe Combined Immunodeficient Mice
Stem Cells,
November 1, 2004;
22(6):
1085 - 1100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Bonig, G. V. Priestley, L. M. Nilsson, Y. Jiang, and T. Papayannopoulou
PTX-sensitive signals in bone marrow homing of fetal and adult hematopoietic progenitor cells
Blood,
October 15, 2004;
104(8):
2299 - 2306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kimura, A. M. Boehmler, G. Seitz, S. Kuci, T. Wiesner, V. Brinkmann, L. Kanz, and R. Mohle
The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells
Blood,
June 15, 2004;
103(12):
4478 - 4486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tavor, I. Petit, S. Porozov, A. Avigdor, A. Dar, L. Leider-Trejo, N. Shemtov, V. Deutsch, E. Naparstek, A. Nagler, et al.
CXCR4 Regulates Migration and Development of Human Acute Myelogenous Leukemia Stem Cells in Transplanted NOD/SCID Mice
Cancer Res.,
April 15, 2004;
64(8):
2817 - 2824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kahn, T. Byk, L. Jansson-Sjostrand, I. Petit, S. Shivtiel, A. Nagler, I. Hardan, V. Deutsch, Z. Gazit, D. Gazit, et al.
Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation
Blood,
April 15, 2004;
103(8):
2942 - 2949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Cottler-Fox, T. Lapidot, I. Petit, O. Kollet, J. F. DiPersio, D. Link, and S. Devine
Stem Cell Mobilization
Hematology,
January 1, 2003;
2003(1):
419 - 437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. B. Adams, K. T. Chabner, R. B. Foxall, K. W. Weibrecht, N. P. Rodrigues, D. Dombkowski, R. Fallon, M. C. Poznansky, and D. T. Scadden
Heterologous cells cooperate to augment stem cell migration, homing, and engraftment
Blood,
January 1, 2003;
101(1):
45 - 51.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Kollet, I. Petit, J. Kahn, S. Samira, A. Dar, A. Peled, V. Deutsch, M. Gunetti, W. Piacibello, A. Nagler, et al.
Human CD34+CXCR4- sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation
Blood,
September 26, 2002;
100(8):
2778 - 2786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Narayanasami, R. Kanteti, J. Morelli, A. Klekar, A. Al-Olama, C. Keating, C. O'Connor, E. Berkman, J. K. Erban, K. A. Sprague, et al.
Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation
Blood,
October 1, 2001;
98(7):
2059 - 2064.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|